203 related articles for article (PubMed ID: 8823314)
1. Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.
Robin MA; Maratrat M; Le Roy M; Le Breton FP; Bonierbale E; Dansette P; Ballet F; Mansuy D; Pessayre D
J Clin Invest; 1996 Sep; 98(6):1471-80. PubMed ID: 8823314
[TBL] [Abstract][Full Text] [Related]
2. Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs.
Lecoeur S; Bonierbale E; Challine D; Gautier JC; Valadon P; Dansette PM; Catinot R; Ballet F; Mansuy D; Beaune PH
Chem Res Toxicol; 1994; 7(3):434-42. PubMed ID: 8075377
[TBL] [Abstract][Full Text] [Related]
3. Opposite behaviors of reactive metabolites of tienilic acid and its isomer toward liver proteins: use of specific anti-tienilic acid-protein adduct antibodies and the possible relationship with different hepatotoxic effects of the two compounds.
Bonierbale E; Valadon P; Pons C; Desfosses B; Dansette PM; Mansuy D
Chem Res Toxicol; 1999 Mar; 12(3):286-96. PubMed ID: 10077492
[TBL] [Abstract][Full Text] [Related]
4. Detection of human hepatitis anti-liver kidney microsomes (LKM2) autoantibodies on rat liver sections is predominantly due to reactivity with rat liver P-450 IIC11.
Pons C; Dansette PM; Amar C; Jaouen M; Wolf CR; Gregeois J; Homberg JC; Mansuy D
J Pharmacol Exp Ther; 1991 Dec; 259(3):1328-34. PubMed ID: 1762080
[TBL] [Abstract][Full Text] [Related]
5. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.
Beaune P; Dansette PM; Mansuy D; Kiffel L; Finck M; Amar C; Leroux JP; Homberg JC
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):551-5. PubMed ID: 3540968
[TBL] [Abstract][Full Text] [Related]
6. Tienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9.
Lecoeur S; André C; Beaune PH
Mol Pharmacol; 1996 Aug; 50(2):326-33. PubMed ID: 8700140
[TBL] [Abstract][Full Text] [Related]
7. Human-liver cytochromes P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10.
Lopez Garcia MP; Dansette PM; Valadon P; Amar C; Beaune PH; Guengerich FP; Mansuy D
Eur J Biochem; 1993 Apr; 213(1):223-32. PubMed ID: 8477697
[TBL] [Abstract][Full Text] [Related]
8. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
9. Involvement of cytochrome P450-mediated metabolism in tienilic acid hepatotoxicity in rats.
Nishiya T; Kato M; Suzuki T; Maru C; Kataoka H; Hattori C; Mori K; Jindo T; Tanaka Y; Manabe S
Toxicol Lett; 2008 Dec; 183(1-3):81-9. PubMed ID: 18992796
[TBL] [Abstract][Full Text] [Related]
10. Immunotoxicology and expression of human cytochrome P450 in microorganisms.
Beaune P; Bourdi M; Belloc C; Gautier JC; Guengerich FP; Valadon P
Toxicology; 1993 Oct; 82(1-3):53-60. PubMed ID: 8236281
[TBL] [Abstract][Full Text] [Related]
11. Immune mechanisms in tienilic acid associated hepatotoxicity.
Neuberger J; Williams R
Gut; 1989 Apr; 30(4):515-9. PubMed ID: 2714684
[TBL] [Abstract][Full Text] [Related]
12. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
Bourdi M; Gautier JC; Mircheva J; Larrey D; Guillouzo A; Andre C; Belloc C; Beaune PH
Mol Pharmacol; 1992 Aug; 42(2):280-5. PubMed ID: 1513326
[TBL] [Abstract][Full Text] [Related]
13. The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytes.
Tinel M; Robin MA; Doostzadeh J; Maratrat M; Ballet F; Fardel N; el Kahwaji J; Beaune P; Daujat M; Labbe G
Gastroenterology; 1995 Nov; 109(5):1589-99. PubMed ID: 7557143
[TBL] [Abstract][Full Text] [Related]
14. Anti-cytochrome P450 autoantibodies in drug-induced disease.
Beaune PH; Lecoeur S; Bourdi M; Gauffre A; Belloc C; Dansette P; Mansuy D
Eur J Haematol Suppl; 1996; 60():89-92. PubMed ID: 8987248
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of tienilic acid bioactivation and functional generation of drug-protein adducts in intact rat hepatocytes.
López-García MP; Dansette PM; Coloma J
Biochem Pharmacol; 2005 Dec; 70(12):1870-82. PubMed ID: 16257391
[TBL] [Abstract][Full Text] [Related]
16. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
Bourdi M; Larrey D; Nataf J; Bernuau J; Pessayre D; Iwasaki M; Guengerich FP; Beaune PH
J Clin Invest; 1990 Jun; 85(6):1967-73. PubMed ID: 2347920
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes.
Robin MA; Maratrat M; Loeper J; Durand-Schneider AM; Tinel M; Ballet F; Beaune P; Feldmann G; Pessayre D
Gastroenterology; 1995 Apr; 108(4):1110-23. PubMed ID: 7698579
[TBL] [Abstract][Full Text] [Related]
18. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis.
Homberg JC; Andre C; Abuaf N
Clin Exp Immunol; 1984 Mar; 55(3):561-70. PubMed ID: 6368059
[TBL] [Abstract][Full Text] [Related]
19. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
Murray M
Mol Pharmacol; 1992 Nov; 42(5):931-8. PubMed ID: 1435757
[TBL] [Abstract][Full Text] [Related]
20. Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions.
Leeder JS; Riley RJ; Cook VA; Spielberg SP
J Pharmacol Exp Ther; 1992 Oct; 263(1):360-7. PubMed ID: 1403797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
